Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

TMPRSS2 affects COVID-19 severity and treatment options.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

0.5% TPGS boosts hair growth with minoxidil, but 2% TPGS increases minoxidil absorption.

Blocking mTORC1 reduces skin tumor growth in mice.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

GRF is not safe for tubal occlusion.

Combination therapy is more effective for prostate volumes over 60 ml.

XEDAR deficiency prevents muscle degeneration in EDA-A2 transgenic mice.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

A simple, precise method was created for estimating Tamsulosin and Finasteride in medicine using common lab solvents, showing good precision and stability.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.